FindTrial
Sign In

Copper Cu 64-DOTA-pembrolizumab

RADIATION3 trials

Sponsors

City of Hope Medical Center

Conditions

Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmMetastatic Lung Non-Small Cell CarcinomaMetastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid NeoplasmOligoprogressive Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8

Early Phase 1

64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation
WithdrawnNCT05728372
City of Hope Medical CenterMetastatic Malignant Solid Neoplasm
Start: 2023-08-25End: 2026-11-08Updated: 2023-10-10

Phase 1

64Cu-DOTA-pembrolizumab PET for the Study of PD1 Expression
WithdrawnNCT04605614
City of Hope Medical CenterHematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Start: 2022-04-15End: 2022-05-16Updated: 2026-08-12
A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab
RecruitingNCT07619599
City of Hope Medical CenterMetastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Neoplasm in the Brain, Oligoprogressive Lung Non-Small Cell Carcinoma +1
Start: 2026-09-14End: 2028-12-22Target: 6Updated: 2026-08-12